Vistagen Therapeutics, Inc. (VTGN)
NASDAQ: VTGN · Real-Time Price · USD
2.320
+0.080 (3.57%)
At close: May 12, 2025, 4:00 PM
2.320
0.00 (0.00%)
After-hours: May 12, 2025, 7:12 PM EDT
Vistagen Therapeutics Employees
As of March 31, 2024, Vistagen Therapeutics had 40 total employees, including 39 full-time and 1 part-time employees. The number of employees increased by 6 or 17.65% compared to the previous year.
Employees
40
Change (1Y)
6
Growth (1Y)
17.65%
Revenue / Employee
$17,450
Profits / Employee
-$1,182,600
Market Cap
66.96M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 94,300 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
VTGN News
- 25 days ago - Vistagen Presents New Research on the Impact of Social Anxiety Disorder at The Anxiety and Depression Association 2025 Conference - Business Wire
- 7 weeks ago - Vistagen to Present at the 2025 Anxiety and Depression Association Conference - Business Wire
- 2 months ago - Vistagen to Participate in Stifel 2025 Virtual CNS Forum - Business Wire
- 2 months ago - Vistagen to Participate in the 45th Annual TD Cowen Healthcare Conference - Business Wire
- 3 months ago - Vistagen: Pherine Candidate Proof Of Concept Continues With Fifth Indication - Seeking Alpha
- 3 months ago - Vistagen Therapeutics, Inc. (VTGN) Q3 2025 Earnings Call Transcript - Seeking Alpha
- 3 months ago - Vistagen Reports Fiscal Year 2025 Third Quarter Financial Results and Corporate Update - Business Wire
- 3 months ago - Vistagen to Report Fiscal Year 2025 Third Quarter Results and Host Corporate Update Conference Call on February 13, 2025 - Business Wire